Testing kits are the key to getting businesses back to work and with the COVID-19 testing kits companies can determine if employees carry the asymmetric virus, or currently carry the virus. And just as important, testing provides assurance to healthy employees who are willing to return to the workplace.

For service businesses, it is essential to test your employees frequently to provide a safe and healthy workplace and peace of mind to your clients and customers.

Li Xu International is currently providing access to quality testing kits made in China and other Asian countries. The following are selected products for the OUS (outside US) global market. The following is the most up to date market info and tips for procuring kits as of April 16, 2020.  Please see product booklet for details and detailed FAQ for answers to the most commonly asked questions.

Product A: Blood-based Testing Kits (IgG/IgM) 

CFDA, CE, FDA pending

10K – 50K kits: $9.5USD/kit, 100% T/T; 100K+ kits: $8.5 USD/Kit, 100% T/T

*400 sample kits and clinical trial tech consulting: $20,000 USD

Interested parties, please complete the customer inquiry sheet.

 Product B: RT-PCR Testing Kits (swab based), Including RNA Extraction

CFDA, CE, FDA pending

10K – 50K kits: $13.5 USD/kit, 100% T/T; 100K+ kits: $11.5 USD/Kit, 100% T/T

*400 sample kits and NO clinical trial tech support: $10,000 USD

Interested parties, please complete the customer inquiry sheet.

 COVID-19 Related Services

  • Product procurement: PPE, hospital use robots, AI-based CT scanners, etc.
  • Technology licensing agreements
  • Set up JV, partnerships, acquisitions
  • US FDA and CFDA strategic consulting, protocol design, and clinical trial turnkey services
  • Lease FDA or CFDA or CE approved production lines

Services are provided via agreed-upon consulting engagements: For a complete list of services, please click the link.

 US Specific

Li Xu International recommends buyers wait for testing kits products with FDA EUA or formal FDA approvals. Meanwhile we welcome qualified distributors and labs to discuss exclusive licensing agreements and distribution rights in the US for the two selected companies currently under FDA pending status.

 Limited Customer Service for Medical Supplies Operation

We value quality and speed and have provided current and sufficient information for experienced business owners to navigate the process of procuring the product.  We are focusing on serving our current and potential customers who are ready to act immediately and take advantage of the opportunity the global market offers.

To help facilitate the process, please complete the customer inquiry sheet.

Share This